Kador P F, Kinoshita J H, Tung W H, Chylack L T
Invest Ophthalmol Vis Sci. 1980 Aug;19(8):980-2.
The susceptibility of human lens aldose reductase (HLAR), human placental aldose reductase (HPAR), and rat lens aldose reductase (RLAR) to inhibition by 10 structurally diverse inhibitors is compared. Significant differences in the susceptibility of these enzymes was observed; however, no trends could be predicted. In general, HPAR appeared to be less susceptible to inhibition than either HLAR or RLAR, with the susceptibility of HLAR being more similar to RLAR than to HPAR. These findings indicate that the evaluation of aldose reductase inhibitors for potential clinical use may require the use of human aldose reductase from the appropriate target tissue.
比较了人晶状体醛糖还原酶(HLAR)、人胎盘醛糖还原酶(HPAR)和大鼠晶状体醛糖还原酶(RLAR)对10种结构各异的抑制剂抑制作用的敏感性。观察到这些酶在敏感性上存在显著差异;然而,无法预测出任何趋势。总体而言,HPAR似乎比HLAR或RLAR对抑制作用更不敏感,HLAR的敏感性与RLAR更为相似,而与HPAR不同。这些发现表明,对醛糖还原酶抑制剂进行潜在临床应用评估时,可能需要使用来自适当靶组织的人醛糖还原酶。